An Introduction to Headache Disorders
Headache disorders, most common debilitating disorders in the world, are responsible for almost three quarters of all neurological-related disabilities. Primary headache disorders include migraine, tension headache and cluster headache. The most common type of secondary headache is medication-overuse headache. The past decade has seen substantial breakthroughs in headache management. New therapeutic strategies target the CGRP ligand or receptor, transforming the treatment paradigm for migraine, and proving useful against cluster headache. Another novel strategy are ditans, a new class of acute treatments that target the serotonin 5-HT1F receptor.
Browse video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and peer-reviewed articles from our journal touchREVIEWS in Neurology. This is complimented by a range of educational activities developed in collaboration with our leading expert faculty.
Our supporting partners do not constitute an endorsement of the content on this page.
Headache Disorders Content
A patient’s perspective: Best practice for shared decision making in the prevention and treatment of migraine
A migraine specialist and a patient advocate discuss migraine and how decision making between patient and clinician can improve outcomes
- Appraise the impact of migraine-related disability on patients
- Evaluate the importance of quality of life improvements for patients with episodic migraine
- Apply a shared decision making approach in the acute treatment and prevention of episodic migraine
Oral migraine therapy: targeting calcitonin gene-related peptide (CGRP)
In this short, animated feature, learn about the role of CGRP in the pathophysiology of migraine....
Why change is needed for children and young people living with migraine in the United Kingdom
Rob Music, CEO, The Migraine Trust, United Kingdom Rob Music joined The Migraine Trust as Chief Executive in February 2021. He has over 30 years’ experience working for healthcare charities, starting out as a fundraiser, and before his current position he held similar roles at Jo’s Cervical Cancer Trust and Endometriosis UK. Despite being so […]
A Bird in the Hand: A Neurologist’s Guide to Efficient Tweeting in the Age of Social Media
touchREVIEWS in Neurology 2022;18(2):76–80 DOI: https://doi.org/10.17925/USN.2022.18.2.76
The surge in social media use seems to have become a sign of our times. Social media has ramified into not only our personal lives but, importantly, also our professional lives and will continue to do so in the future.1–4 At the same time, more neurologists resorted to online learning modalities, including podcasts and social media […]
Potential Uses for Precision Tinted Lenses in a Neurology Clinic
touchREVIEWS in Neurology. 2022;18(2):93-102 DOI: https://doi.org/10.17925/USN.2022.18.2.93
Photophobia is a complex disorder that can involve aversion not simply to bright light but to spatial patterns, colour and flicker.1 It is common in neurological diseases that involve the visual system,2 of which migraine is the most prevalent. Tinted lenses have been widely advocated on the internet as a means of reducing photophobia, particularly in migraine, […]
Robert Music, The Migraine Trust: Improving migraine care – ensuring patient-focussed diagnosis and treatment in the UK
“Migraine is a common and complex brain disorder that affects 10 million people in the UK, impacting their ability to work, relationships and mental health. It’s poorly understood by the public and even many health professionals, and there are challenges around diagnosis, care and access to the right treatment. ” – Rob Music, CEO, The […]
Neuromodulation for Prevention and Treatment of Headache Disorders
touchREVIEWS in Neurology. 2022;18(2):103–8 DOI: https://doi.org/10.17925/USN.2022.18.2.103
Neuromodulation is a recent technique that has increasingly been used for the abortive and preventive treatment of migraine and other primary headache disorders.1 It has previously been found to be helpful in the treatment of other neurological illnesses, such as epilepsy.2 Neuromodulation treatment of headache disorders involves pain relief via manipulation of the peripheral or central pain […]
Raquel Gil-Gouveia, EAN 2022: Highlights in headache and migraine – Treatment advances, strategies for prevention, Anti-CGRP use in migraine, COVID-19
Headache is one of the most common nervous system disorders. In an interview with touchNEUROLOGY, Dr Raquel Gil-Gouveia (Hospital da Luz, Lisbon, Portugal) summarizes the ePoster session she chaired at EAN 2022, ranging from topics such as how COVID-19 has impacted on young people with headaches, the potential of new treatments such as eptinezumab and […]
The UK’s Migraine Healthcare System: Key Problems and How They Can be Addressed
touchREVIEWS in Neurology. 2022;18(1):5–6 DOI: https://doi.org/10.17925/USN.2022.18.1.5
For a condition as highly prevalent and debilitating as migraine, there is still too little awareness of it and the impact it has. There is little understanding of the different symptoms and stages of a migraine attack, the frequency with which many people have migraine attacks and how this affects different aspects of their lives. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!